# CELLICO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellico

- Industry: Healthcare Specialists
- Headquarters: Seongnam, South Korea
- Website: http://www.cellico.com
- Latest round: Seed (Mar 1, 2021)
- Investors on record: 3

## About

Based in Seongnam-si, Gyeonggi-do, South Korea, and founded in 2019, CELLICO is a high-tech startup company and is developing an electronic eye or artificial retina product for the visually impaired. The company is an incubator of the Gyeonggi Creative Economy Innovation Center, receiving accelerating support by moving into the Pangyo Startup Zone operated by the Ministry of Small and Medium Venture Business and the Korea Startup Promotion Agency in 2020. In 2021, CELLICO was selected as a childcare company in the Pangyo Startup Zone and as a company approved by the Ministry of Food and Drug Safety.

The company develops a device that inserts a neuromorphic image sensor chip into the damaged visual cell layer of patients with retinal disease converting the sensed light into bioelectrical signals to restore the sight of retinitis pigmentosa and macular degeneration patients.

## Funding rounds

- Seed, Mar 1, 2021 — Shinhan Capital, FuturePlay, Korea Science & Technology Holdings

## Investors

- Shinhan Capital (https://capitalatlas.ai/funds/shinhan-capital) — Seed
- FuturePlay (https://capitalatlas.ai/funds/futureplay) — Seed
- Korea Science & Technology Holdings — Seed